Abstract: Disclosed are methods utilizing specific amplification of Candida sp. target nucleic acid for detecting the presence or absence of Candida sp. in a sample. Also disclosed are corresponding oligomers, including amplification oligomers, capture probes and detection probes, and combinations thereof, as well as corresponding reaction mixtures and kits.
Type:
Grant
Filed:
March 19, 2021
Date of Patent:
April 26, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
Angela S. Hudson, Damon K. Getman, Alice Jiang, Barbara L. Eaton
Abstract: An apparatus for separating an interlocked cap and receptacle comprises a top wall and a cap removal station. The cap removal station comprises an opening, a raised collar for engaging and releasing interlocking elements of the cap and receptacle, and tabs on a side of the top wall opposite the raised collar for retaining the receptacle within the opening when the cap is separated from the receptacle. A method for separating an interlocked cap and receptacle comprises moving the cap and receptacle in a first direction into a cap removal station, contacting interlocking elements of the cap and receptacle with a raised collar to thereby release the interlocking elements, retaining the receptacle within the cap removal station; and with the interlocking elements released and the receptacle retained within the cap removal station, moving the cap in a second direction opposite the first direction to separate the cap from the receptacle.
Abstract: An apparatus configured for mixing the contents of one or more fluid containers includes a fluid container support platform configured to hold one or more fluid containers. The fluid container support platform is configured to index the container to one or more specified locations and to be moved in an orbital path about an orbital center independently of the rotation about the central axis of rotation. The apparatus further includes an indexing drive system configured to effect indexing movement of the container support platform and a vortex drive system configured to effect powered orbital movement of the container support platform about the orbital center. An evaporation limiting insert placed within containers reduces exposure of the fluid contents of the container to atmospheric air, thereby reducing susceptibility of the fluid contents to evaporation.
Abstract: Compositions, methods, kits, and uses are provided for detecting or quantifying a Group A Streptococcus (GAS) nucleic acid, e.g., using nucleic acid amplification and hybridization assays.
Abstract: A cover assembly may include a tray assembly frame, a first cover supported by the tray assembly frame, the first cover extending in a first plane and defining one or more first openings; a second cover supported by the tray assembly frame, the second cover extending in a second plane and defining one or more second openings, wherein the first and second planes are different planes, and wherein the second cover is disposed above the first cover. The cover assembly may include one or more tray holders, each tray holder being configured to hold at least one tray in an upright orientation, wherein each tray holder is moveable between an open position and a closed position, the tray holders being accessible for loading or removing the trays in the open position, and the tray holders being positioned beneath the first and second covers in the closed position.
Abstract: There is disclosed a composition of an aqueous solution comprising, consisting or consisting essentially of a flap endonuclease, a bulking agent and an organic buffer, wherein the aqueous solution has an inorganic salt concentration of 5 mM or less and wherein the composition is substantially free of glycerol.
Type:
Grant
Filed:
May 18, 2018
Date of Patent:
March 29, 2022
Assignee:
Gen-Probe Incorporated
Inventors:
Patrick Peterson, Tony Luu, Matthias Jost
Abstract: A system for performing a nucleic acid amplification assay that includes a receptacle holder formed from a thermally conductive material and having a receptacle well for receiving a lower portion of a vial; a thermal element for cycling the temperature of the receptacle holder; a signal detection module in optical communication with the receptacle well; and a robotic pipettor. The receptacle holder supports a capped vial having a plastic, opaque cap in a snap-fit with a single plastic vial containing a nucleic acid amplification reagent. An upper portion of the cap includes a probe recess that is configured to be removably engaged by an end of a probe of the robotic pipettor. A lower portion of the vial is contained within the receptacle well, and the cap is situated above a top surface of the receptacle holder.
Type:
Grant
Filed:
September 29, 2020
Date of Patent:
March 22, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
David A. Buse, David Howard Combs, Byron J. Knight, Norbert D. Hagen, David Opalsky, Jason F. Rhubottom, Keith Moravick, Tyler Moore, Anita Prasad, Bruce Richardson
Abstract: Method and system for quantifying target nucleic acids using real-time amplification and internal calibration adjustment. The invention employs dual reference calibration curves for approximating a complete calibration curve from only a single adjustment calibrator amplified on the instrument that is to be calibrated.
Type:
Grant
Filed:
March 6, 2018
Date of Patent:
March 15, 2022
Assignee:
Gen-Probe Incorporated
Inventors:
Michael J. Gilly, Sangeetha Vijaysri Nair, James M. Carrick, Xianqun Wang, Susan K. Yamagata
Abstract: A method for reading machine-readable labels on a plurality of sample receptacles held by a sample rack. The sample rack is moved between first and second positions within a housing and a label reader is activated at each of a plurality of predetermined position between the first and second positions to read the machine-readable label of each of the plurality of sample receptacles.
Type:
Grant
Filed:
June 18, 2020
Date of Patent:
March 15, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
Norbert D. Hagen, David Opalsky, Rolf Silbert
Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis B virus (HBV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the P and/or S open reading frames of HBV and are configured to provide substantially equivalent quantification of different genotypes and variants of HBV.
Abstract: Nucleic acid oligomers specific for human parvovirus genomic DNA are disclosed. An assay for amplifying and detecting human parvovirus genotypes 1, 2 and 3 nucleic acid in biological specimens is disclosed. Compositions for amplifying and detecting the presence of human parvovirus genotypes 1, 2 and 3 genomic DNA in human biological specimens are disclosed.
Type:
Grant
Filed:
June 9, 2017
Date of Patent:
March 8, 2022
Assignee:
Gen-Probe Incorporated
Inventors:
Kui Gao, Jeffrey M. Linnen, Kurt C. Norton, Patricia C. Gordon, Dat Do, Tan N. Le
Abstract: Disclosed are methods for diagnosing Bacterial Vaginosis in a subject comprising performing an assay for the detection of any one or more of Lactobacillus sp., Gardneralla vaginalis, and Eggerthella sp. in a subject sample. Also disclosed are methods and compositions for detecting Lactobacillus sp., Gardneralla vaginalis, and/or Eggerthella nucleic acid in a sample.
Type:
Grant
Filed:
December 11, 2019
Date of Patent:
March 8, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
Barbara Lynn Eaton, Damon Kittredge Getman, Traci Pawlowski
Abstract: A method of processing a sample in a receptacle comprising a plurality of chambers. Each of the chambers is connected to at least one other chamber by a portal and at least a first one of the chambers is formed of a flexible material. The method includes the steps of causing gas bubbles contained in the first chamber to accumulate in a portion of the first chamber, applying a compressive external force to the first chamber to cause some or all of the liquid contents of the first chamber to flow into an interconnected second chamber through a portal connecting the first and second chambers; and preventing the gas bubbles accumulated in a portion of the first chamber from flowing through the portal into the second chamber.
Type:
Grant
Filed:
December 27, 2018
Date of Patent:
February 1, 2022
Assignees:
GEN-PROBE INCORPORATED, QUALIGEN, INC.
Inventors:
Scott S. Breidenthal, Richard S. Lee, Norman C. Nelson, Matthew J. Scott, Jason A. Taylor
Abstract: A receptacle comprises opposed members, a plurality of chambers having perimeter walls defined by seals formed between the opposed members and portals interconnecting the chambers, and a rigid frame supporting the opposed members at their peripheral edges. The frame comprises a front frame portion and a rear frame portion, and the peripheral edges of the opposed members are retained between the front and rear frame portions. An inlet port extends between the front and rear frame portions and is in fluid communication with one of the chambers.
Type:
Grant
Filed:
December 27, 2018
Date of Patent:
February 1, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
Scott S. Breidenthal, Richard S. Lee, Norman C. Nelson, Matthew J. Scott, Jason A. Taylor
Abstract: Receptacles containing a reaction mixture are transported to receptacle wells of a thermally conductive receptacle holder, and the temperature of the holder is cycled with a thermoelectric device situated between a support and a first side of the holder while a first force is applied onto a second side of the holder. Optical communication between each well and an excitation signal source and an emission signal detector is established to determine whether an emission signal is emitted from any of the receptacles during temperature cycling as an indication of the presence of a target nucleic acid. The thermoelectric device may be situated between an upright portion of the support and the first side of the holder. A second force may be applied onto a top end of each receptacle in the holder by a cover moveable with respect to the receptacles between an open position and a closed position.
Type:
Grant
Filed:
September 18, 2020
Date of Patent:
January 25, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
David Buse, David Howard Combs, Norbert D. Hagen, David Opalsky, Bruce Richardson, Anita Prasad, Keith Moravick, Tyler Moore, Byron J. Knight
Abstract: Disclosed are oligonucleotides, oligonucleotide compositions, kits, methods, formulations, and reaction mixtures that provide for sensitive and specific detection of a target nucleic acid sequence, or amplicon generated from a target nucleic acid sequence, of Varicella-Zoster Virus (VZV1 (if present) in a sample. The oligonucleotides, compositions, kits, methods, formulations, and reaction mixtures can be used to detect the presence of VZV in a sample. The oligonucleotides, compositions, kits, methods, formulations, and reaction mixtures can also be used to amplify specific target nucleic acid regions of VZV.
Type:
Application
Filed:
October 1, 2019
Publication date:
January 20, 2022
Applicant:
GEN-PROBE INCORPORATED
Inventors:
Marcela Alejandra CARVALLO PINTO, Amber Jean HILLIUS, Ankur SHAH
Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis B virus (HBV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the P and/or S open reading frames of HBV and are configured to provide substantially equivalent quantification of different genotypes and variants of HBV.
Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
Type:
Grant
Filed:
April 29, 2019
Date of Patent:
February 1, 2022
Assignee:
GEN-PROBE INCORPORATED
Inventors:
Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam